MedPath

青岛国信制药有限公司

Ownership
-
Established
1994-11-24
Employees
-
Market Cap
-
Website
https://www.cppqd.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

64

NMPA:64

Drug Approvals

Eldecalcitol Soft Capsules

Product Name
艾地骨化醇软胶囊
Approval Number
国药准字H20253727
Approval Date
Mar 25, 2025
NMPA

Eldecalcitol Soft Capsules

Product Name
艾地骨化醇软胶囊
Approval Number
国药准字H20253728
Approval Date
Mar 25, 2025
NMPA

Frovatriptan succinate Tablets

Product Name
琥珀酸呋罗曲坦片
Approval Number
国药准字H20244535
Approval Date
Jul 30, 2024
NMPA

丹桂香胶囊

Approval Number
国药准字Z20080358
Approval Date
Jun 24, 2023
NMPA

Calcitriol Oral Solution

Product Name
骨化三醇口服溶液
Approval Number
国药准字H20233715
Approval Date
Jun 14, 2023
NMPA

Paricalcitol Injection

Product Name
帕立骨化醇注射液
Approval Number
国药准字H20213094
Approval Date
Feb 2, 2021
NMPA

Compound Hydrobromide Dextromethorphan Oral Solution

Product Name
彤贝得
Approval Number
国药准字H20041491
Approval Date
Apr 24, 2020
NMPA

Erythromycin Ethylsuccinate Tablets

Product Name
琥乙红霉素片
Approval Number
国药准字H20046448
Approval Date
Feb 3, 2020
NMPA

丹桂香颗粒

Approval Number
国药准字Z10980011
Approval Date
Feb 3, 2020
NMPA

Sulindac Tablets

Product Name
舒林酸片
Approval Number
国药准字H20033535
Approval Date
Feb 3, 2020
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.